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Abstract
Background: Spermidine, a naturally occurring polyamine, displays a wide variety of internal biological activities
including cell growth and proliferation. However, the molecular mechanisms responsible for its anti-inflammatory
activity have not yet been elucidated.
Methods: The anti-inflammatory properties of spermidine were studied using lipopolysaccharide (LPS)-stimulated
murine BV2 microglia model. As inflammatory parameters, the production of nitric oxide (NO), prostaglandin E2
(PGE2), interleukin (IL)-6 and tumor necrosis factor (TNF)-a were evaluated. We also examined the spermidine’s
effect on the activity of nuclear factor-kappaB (NF-B), and the phosphoinositide 3-kinase (PI3K)/Akt and mitogen-
activated protein kinases (MAPKs) pathways.
Results: Pretreatment with spermidine prior to LPS treatment significantly inhibited excessive production of NO
and PGE2 in a dose-dependent manner, and was associated with down-regulation of expression of inducible nitric
oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). Spermidine treatment also attenuated the production of pro-
inflammatory cytokines, including IL-6 and TNF-a, by suppressing their mRNA expressions. The mechanism
underlying spermidine-mediated attenuation of inflammation in BV2 cells appeared to involve the suppression of
translocation of NF-B p65 subunit into the nucleus, and the phosphorylation of Akt and MAPKs.
Conclusions: The results indicate that spermidine appears to inhibit inflammation stimulated by LPS by blocking
the NF-B, PI3K/Akt and MAPKs signaling pathways in microglia.
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Background
Microglia are glial cells that function as the prime effec-
tor cells in the immune defense and inflammatory
responses in the central nervous system (CNS) [1-3].
These cells are activated in response to environmental
stress and produce various bioactive molecules, includ-
ing nitric oxide (NO), prostaglandin E2 (PGE2), reactive
oxygen species, and pro-inflammatory cytokines, such as
interleukin (IL)-1b, IL-6, and tumor necrosis factor
(TNF)-a, which function to restore CNS homeostasis by
clearing damaged cells and debris [4,5]. However, pro-
longed microglial activation can cause chronic neuroin-
flammation and promote neuronal injury due to
increased production of neurotoxic pro-inflammatory
mediators, and can eventually lead to neuronal death
[1,2,6]. This is a common characteristic found in several
neurodegenerative diseases [7,8]. Control of microglial
activation and subsequent suppression of the production
of neurotoxic pro-inflammatory molecules would there-
fore be an effective therapeutic option for treatment of
various neurodegenerative diseases.
Naturally occurring polyamines such as spermidine,
spermine, and their precursor putrescine, are thought to
play several important control functions in cells, ranging
from basic DNA synthesis to regulation of cell prolifera-
tion and differentiation [9-11]. Chemically, polyamines
are cationic molecules with positive charges that enable
electrostatic interactions with polyanionic macromole-
cules within living cells [12-14]. Several recent studies
have suggested that polyamines exert multiple effects
including anti-oxidant and anti-inflammatory benefits.
For example, Kitagawa and colleagues reported that
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lipid peroxidation [15-18]. Merentie et al. [19] showed
in a pancreatitis model that polyamines could prevent
damage to membrane structure caused by activated oxy-
gen radicals by preventing the production of TNF-a and
IL-6 production.
Spermidine is a ubiquitous polycation that is synthe-
sized from putrescine and serves as a precursor of sper-
mine. The pancreas is the richest source of spermidine
in the body. Eisenberg et al. [20] indicated that an exo-
genous supply of spermidine prolongs the life span of
several model organisms, and significantly reduces age-
related oxidative protein damage in mice. These
responses suggest that spermidine may act as a universal
anti-aging drug. However, the actual molecular mechan-
isms or signal transduction cascades that underlie sper-
midine-induced responses, such as anti-inflammatory
effects, have not yet been clarified. The present study
was designed to evaluate the anti-inflammatory effects
of spermidine following lipopolysaccharide (LPS) stimu-
lation of BV2 microglial cells.
Methods
Cell culture and cell viability assay
The BV2 immortalized murine microglial cells con-
structed by infecting primary microglia with a v-raf/v-
myc oncogene-carrying retrovirus (J2) were provided
by Prof. I.W. Choi (Inje University, Busan, Republic of
Korea). The cells were cultured in Dulbecco’s modified
Eagle’s medium (DMEM, Gibco-BRL, Grand Island,
NY) supplemented with 10% fetal bovine serum (FBS),
penicillin (100 units/ml), and streptomycin (100 μg/
ml). Cells were maintained in a humidified incubator
with 5% CO2. Spermidine was purchased from Sigma-
Aldrich Chemical Co. (St. Louis, MO) and dissolved in
dimethyl sulfoxide (DMSO, Sigma-Aldrich) as a 1 M
stock solution, and dilutions were made in DMEM.
The final concentration of DMSO in the medium was
less than 0.05% (vol/vol) which showed no influence
on cell growth. In all experiments, cells were pre-
treated with the indicated concentrations of spermi-
dine for 1 h before addition of LPS (0.5 μg/ml, Sigma-
Aldrich). The MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide, Sigma-Aldrich] reduction
assay was used for determination of cell viability. In
brief, BV2 cells (3 × 10
5 cells/well) were seeded and
treated with various reagents for the indicated time
periods. After various treatments, the medium was
removed and the cells were incubated with 0.5 mg/ml
of MTT solution. After incubation for 2 h at 37°C and
5% CO2, the supernatant was removed and formation
of formazan was measured at 540 nm with a micro-
plate reader (Dynatech MR-7000; Dynatech Labora-
tories, Chantilly, VA).
Isolation of total RNA and reverse transcription-PCR
Total RNA was prepared using TRIzol reagent (Invitro-
gen, CA) and primed with random hexamers for synth-
esis of complementary DNA using M-MLV reverse
transcriptase (Promega, Madison, WI), according to the
manufacturer’s instructions using DNAse I (1 U/μg
RNA) pretreated total mRNA. Single stranded cDNA
was amplified by polymerase chain reaction (PCR) with
primers for inducible nitric oxide synthase (iNOS),
cyclooxygenase (COX)-2, IL-1b,T N F - a, and glycerald-
hyde-3-phosphate dehydrogenase (GAPDH). The follow-
ing PCR conditions were applied: GAPDH: 18 cycles of
denaturation at 94°C for 30 s, annealing at 57°C for 30
s, and extension at 72°C for 30 s; iNOS, COX-2, IL-6,
and TNF-a: 25 cycles of denaturation at 94°C for 30 s,
annealing at 52°C for 30 s, and extension at 72°C for 30
s. GAPDH was used as an internal control to evaluate
relative expression of COX-2, iNOS, IL-6, and TNF-a
Western blot analysis
Cells were washed with PBS three times, placed at a tem-
perature of 4°C, and lysed for 30 min in lysis buffer (20
mM sucrose, 1 mM EDTA, 20 μMT r i s - C l ,p H7 . 2 ,1
mM DTT, 10 mM KCl, 1.5 mM MgCl2 and 5 μg/ml
aprotinin). Lysates were then centrifuged at 12,000 rpm
at 4°C. The protein concentration was measured using a
Bio-Rad protein assay (Bio-Rad Lab., Hercules, CA)
according to the manufacturer’s instructions. Equal
amounts of protein (30-50 μg) were separated electro-
phoretically using 8-10% sodium dodecyl sulfate (SDS)-
polyacrylamide gel electrophoresis; the gel was then
transferred to 0.45 μm polyvinylidene fluoride (PVDF:
Millipore, Bedford, MA). Membranes were soaked in
blocking buffer (5% skimmed milk) and then incubated
with primary antibodies. After thorough washing with
PBST, horseradish peroxidase conjugated antibodies
were applied and immune complexes were then visua-
lized using the enhanced chemiluminescence (ECL)
detection system according to the recommended proce-
dure (Amersham). In a parallel experiment, cells were
washed with ice-cold PBS and scraped; and cytoplasmic
and nuclear proteins were then extracted using NE-PER
®
Nuclear and Cytoplasmic Extraction Reagents (Pierce
Biotechnology, Rockford, IL). For Western blot analysis,
rabbit anti-human iNOS, COX-2, p65, and IB-a poly-
clonal antibodies were purchased from Santa Cruz Bio-
technology (Santa Cruz, CA). Antibodies against
extracellular signal-regulated kinase (ERK), phosphory-
lated (p)-ERK, p38 mitogen-activated protein kinase
(MAPK), p-p38 MAPK, c-Jun N-terminal kinase (JNK),
p-JNK, Akt, p-Akt, and lamin B were purchased from
Cell Signaling Technology (Danvers, MA). The peroxi-
dase-labeled donkey anti-rabbit immunoglobulin and
peroxidase-labeled sheep anti-mouse immunoglobulin
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Heights, IL).
Nitrite determination
Levels of NO in culture supernatants were measured by
use of the Griess reaction. BV2 cells (4 × 10
5 cells/ml)
were seeded in six-well plates and stimulated for 24 h
with LPS in either the presence or absence of various
concentrations of spermidine. Following LPS stimula-
tion, 100 μl of the conditioned culture medium from
each sample was mixed with the same volume of Griess
reagent [1% sulfanilamide/0.1% N-(1-naphthyl)-ethylene-
diamine dihydrochloride/2.5% H3PO4]. NO concentra-
tion was determined by measurement of absorbance at
540 nm using a microplate spectrophotometer (Dyna-
tech MR-7000). Nitrite concentration was calculated
with reference to a standard curve of sodium nitrite
generated by known concentrations [21].
Measurement of PGE2
BV2 cells were plated at a density of 4 × 10
5 cells/ml in
a six-well cell culture plate and incubated with various
concentrations of spermidine in either the presence or
absence of LPS (0.5 μg/ml) for 24 h. Following the man-
ufacturer’s instructions, a volume of 100 μlo fc u l t u r e -
medium supernatant was collected for determination of
PGE2 concentration by ELISA (Cayman, MI) [22].
Enzyme-linked immunosorbent assay (ELISA)
Following the manufacturer’s instructions, the levels of
cytokines, IL-6, and TNF-a, were measured by use of
ELISA kits (R&D Systems, Minneapolis, MN). Absor-
bance was determined at 450 nm using a microplate
reader [23].
Immunofluorescence analysis
For detection of NF-B p65 translocation, cells were
g r o w no ng l a s sc o v e r s l i p sf o r2 4ha n dt h e nt r e a t e d
with 0.5 μg/ml LPS, which were either pretreated or
not pretreated with spermidine for 60 min. Cells were
fixed with 3.7% paraformaldehyde, treated with 0.2%
Triton X-100, and blocked with 2% bovine serum albu-
min (BSA, Sigma-Aldrich). Cells were then sequentially
incubated with anti-NF-B p65 antibody, FITC-conju-
gated donkey anti-rabbit IgG, and 4,6-diamidino-2-
phenylindole (DAPI, Sigma-Aldrich) solution, and
examined using a fluorescence microscope (Carl Zeiss,
Germany).
Statistical analysis
Data are presented as the mean ± SD of at least three
separate experiments. Comparisons between the two
groups were analyzed using the Student’s t-test. P values
less than 0.05 were considered statistically significant.
Results
Spermidine inhibits NO and PGE2 production in LPS-
stimulated BV2 microglia
We first examined whether spermidine could regulate
production of NO and PGE2 produced by microglia.
The effect of spermidine on LPS-induced NO and PGE2
production was studied by pretreating cells with spermi-
dine for 1 h prior to LPS stimulation for 24 h. The NO
and PGE2 levels in the cell culture media were then
measured. As shown in Figure 1, LPS alone markedly
induced NO and PGE2 production, compared to the
control; however, both NO and PGE2 production by
LPS-activated cells were significantly inhibited by sper-
midine in a concentration-dependent manner. Pretreat-
ment with spermidine therefore significantly suppressed
expression of LPS-mediated pro-inflammatory media-
tors. The selected concentrations of spermidine used in
our experiment did not exhibit any significant
Figure 1 Effects of spermidine on LPS-induced NO and PGE2
production in BV2 microglia. (A) Cells were treated with the
indicated concentrations of spermidine 1 h before a 24 h LPS
treatment. Amounts of NO were determined using Griess reagent
and a standard curve was created using NaNO2 in culture medium.
Control values were obtained in the absence of LPS or spermidine.
(B) Following the manufacturer’s instructions, levels of PGE2 in the
media were detected using a specific enzyme immunoassay. Each
value indicates the mean ± S.D. of three independent experiments.
*P < 0.05 indicates a significant difference from cells treated with
LPS in the absence of spermidine.
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for up to 24 h of incubation, in all cases, cell viability
remained above 95% as determined by the MTT assay
(data not shown). This confirmed that the observed
inhibition of NO and PGE2 production in LPS-stimu-
lated BV2 cells was not due to a cytotoxic action of
spermidine or LPS.
Spermidine attenuates expression of LPS-stimulated iNOS
and COX-2 mRNA and protein
We carried out RT-PCR and Western blot analyses to
investigate the question of whether inhibition of NO
and PGE2 production were associated with decreased
levels of iNOS and COX-2 expression. As shown in Fig-
ure 2A and 2B, iNOS and COX-2 mRNA was detected
6 h after LPS treatment, and the enzyme proteins were
detected in whole cell lysates 24 h after LPS treatment.
However, spermidine treatment of LPS-stimulated BV2
microglia significantly decreased both iNOS and COX-2
mRNA and protein levels. Spermidine-induced
reduction in expression of iNOS and COX-2 was appar-
ently responsible for the observed inhibition of NO and
PGE2 production.
Spermidine suppresses production of inflammatory
cytokines in LPS-stimulated BV2 microglia
We next investigated whether spermidine suppresses
production of pro-inflammatory cytokines, such as IL-6
and TNF-a, in LPS-stimulated BV2 cells. For this study,
BV2 microglia were incubated with spermidine in the
absence or presence of LPS for 24 h, and the cytokine
levels in the culture supernatants were evaluated. As
indicated in Figure 3A and 2B, the production of IL-6
and TNF-a induced by LPS treatment was significantly
decreased by treatment with spermidine. In a parallel
experiment, using RT-PCR, we studied the effects of
spermidine on LPS-induced IL-6 and TNF-a mRNA
expression. As shown in Figure 4, the levels of expres-
sion of IL-6 and TNF-a mRNA also decreased in
response to spermidine treatment. These results suggest
Figure 2 Effects of spermidine on LPS-induced expression of
iNOS and COX-2 mRNA and protein in BV2 microglia. (A) BV2
cells were pretreated with different concentrations of spermidine for
1 h followed by LPS stimulation for another 6 h. Total RNAs were
isolated, and mRNA levels of iNOS and COX-2 were measured by
RT-PCR. GAPDH expression was used as an internal control. (B) After
24 h treatment, the cells were lysed and the cellular proteins (50
μg) were separated by electrophoresis on SDS-polyacrylamide gels
and transferred onto nitrocellulose membranes. The membranes
were probed with the indicated antibodies and the proteins were
visualized using an ECL detection system. ERK was used as an
internal control.
Figure 3 Effects of spermidine on pro-inflammatory cytokine
production in LPS-stimulated BV2 microglia. Cells were
pretreated with the indicated concentrations of spermidine for 1 h
before LPS treatment. Following incubation for 24 h, the
supernatants were analyzed for IL-6 (A) and TNF-a (B) content. Each
value indicates the mean ± S.D. of three independent experiments.
*P < 0.05 indicates a significant difference from cells treated with
LPS in the absence of spermidine.
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matory cytokine production in activated microglia
through alteration of the transcription levels of IL-6 and
TNF-a.
Spermidine blocks NF-B activity in LPS-stimulated BV2
microglia
Activation of NF-B is the key event for the induction
of all major pro-inflammatory mediators. Therefore, we
used Western blotting and immunofluorescence micro-
scopy to examine the effect of spermidine on NF-B
activation. As shown in Figure 5A, immunoblotting
results indicated that stimulation of cells with LPS
induced the degradation of IBa, and translocation of
the NF-B p65 subunit from the cytosol to the nucleus.
However, the LPS-induced IB degradation was inhib-
ited following a 30 min of exposure to spermidine. Sper-
midine treatment also inhibited nuclear translocation of
Figure 4 Effects of spermidine on expression of IL-6 and TNF-a mRNA in LPS-stimulated BV2 microglia. Cells were pretreated with the
indicated concentrations of spermidine for 1 h before LPS treatment, and the total RNAs were isolated at 6 h after LPS treatment. The levels of
IL-6 and TNF-a mRNA were determined by RT-PCR. GAPDH was used as internal control.
Figure 5 Effects of spermidine on NF-B activity in LPS-stimulated BV2 microglia. (A) Cells were pretreated with the indicated
concentrations of spermidine 1 h before LPS treatment for the indicated times. Total cytosolic (30 μg) or nuclear (30 μg) proteins were
separated on 10% SDS-polyacrylamide gels, followed by Western blotting using anti-NF-B p65 and IB-a. Proteins were visualized using an ECL
detection system. ERK and lamin B were used as internal controls. (B) NF-B p65 was localized by fluorescence microscopy after
immunofluorescence staining with NF-B p65 antibody (green). Cells were stained with DAPI for visualization of nuclei (blue). Results are
representative of those obtained from three independent experiments.
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scopy results indicated similar responses (Figure 5B).
These results suggest that spermidine may inhibit NF-
B activation in BV2 microglia cells by suppression of
IB degradation and nuclear translocation of NF-B.
Spermidine reduces LPS-induced phosphorylation of Akt
and MAPKs in LPS-stimulated BV2 microglia
We investigated an alternative intracellular mechanism
potentially responsible for the inhibitory effect of sper-
midine on inflammatory mediators by examining the
effect of spermidine on Akt and MAPKs signaling path-
ways. As shown in Figure 6, phosphorylation of Akt was
increased within 15 min after LPS stimulation and sper-
midine pretreatment resulted in marked blockage of this
phosphorylation. Stimulation of BV2 cells with LPS led
to rapid activation of p38 MAPK, ERK, and JNK, with
peak levels of each phospho-MAPK occurring 15 to 60
min after addition of LPS. Spermidine pretreatment sig-
nificantly inhibited this phosphorylation of MAPKs in
LPS-stimulated BV2 microglia (Figure 6). This finding
suggests that spermidine is capable of disrupting key
signal transduction pathways such as Akt and MAPKs
that are activated by LPS in BV2 microglia. This then
prevents production of pro-inflammatory mediators.
Discussion
Inflammation plays an important role in the pathology
of neurodegenerative disorders in the brain. In particu-
lar, neuroinflammation with prolonged activation of
microglial cells leads to an increased production of pro-
inflammatory mediators and cytokines. This contributes
to neuronal dysfunction and neuronal loss and ulti-
mately leads to neuronal cell death [1,2,6]. Therefore,
inhibitors of these inflammatory molecules have been
considered as candidate anti-inflammatory drugs for
alleviation of the progression of neurodegenerative dis-
ease caused by activation of microglia [8,24,25]. In the
present study, we demonstrated that spermidine treat-
ment of activated BV2 microglial cells resulted in signifi-
cant inhibition of the production of the LPS-induced
pro-inflammatory mediators (NO and PGE2) and cyto-
kines, (including TNF-a and IL-6). These effects were
accompanied by down regulation of NF-B, and inacti-
vation of PI3K/Akt and MAPKs signaling pathways.
Therefore, inhibition of pro-inflammatory molecules by
spermidine, as shown in the present study, could be
beneficial in the treatment of neurodegenerative
diseases.
NO is an important regulatory mediator that involved
in cell survival and death, and it also exerts a number of
pro-inflammatory effects in several physiological and
pathological processes. High levels of NO are produced
from L-arginine by iNOS in the brain by prolonged acti-
vation of microglial cells, and this response is associated
with the progression of various neurodegenerative dis-
eases [26]. Similarly, another well-known inflammatory
mediator, PGE2, which is generated from arachidonic
acid via the action of COXs, contributes to the develop-
ment of many chronic inflammatory diseases [27,28].
Overproduction of PGE2 in response to various inflam-
matory stimuli is associated with up-regulation of COX-
2 and progression of inflammation. Overall, COX-2 has
emerged as one of the major players in brain inflamma-
tion, and increased COX-2 expression is believed to
contribute to neurodegeneration [29,30]. Therefore, any
substance that can attenuate expression of iNOS and
COX-2 could be beneficial for preventing and delaying
the progression of neurodegenerative disease.
In the present study, we found that spermidine treat-
ment of LPS-stimulated BV2 cells effectively decreased
iNOS and COX-2 mRNA and protein expression and
the release of their respective end-products, NO and
PGE2 (Figure 1 and 2). These effects were not due to
any cytotoxicity of spermidine, as verified by the MTT
assay. Thus, the observed inhibitions of NO and PGE2
production may be attributed to the suppression of the
transcription of iNOS and COX-2 mRNA and subse-
quent reduction in protein expressions. Therefore, sper-
midine may impart beneficial effects by attenuation of
Figure 6 Effects of spermidine on Akt and MAPKs activation
induced by LPS in BV2 microglia. Cells were treated with
different concentrations of spermidine 1 h before LPS treatment for
the indicated times. Total proteins (50 μg) were separated on 10%
SDS-polyacrylamide gels, followed by Western blotting using the
indicated antibodies. Results are representative of those obtained
from three independent experiments.
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inflammatory neurotoxins.
Pro-inflammatory cytokines, such as IL-1b,I L - 6a n d
TNF-a, are the initiators of the inflammatory response
and the mediators of the development of chronic
inflammatory diseases. Therefore, overproduction of
pro-inflammatory cytokines can be considered as a his-
topathological hallmark of various neurological diseases
in the brain [5,17,31]. The present demonstrated that
spermidine significantly inhibited the generation of IL-6
and TNF-a in LPS-stimulated BV2 microglia in a con-
centration-dependent manner by suppressing mRNA
expressions (Figure 3 and 4). This indicated that the
inhibitory action of spermidine on production of inflam-
matory mediators occurs at the transcriptional level.
The transcription factor NF-B is known to play a criti-
cal role in controlling most inflammatory responses due
to its ability to induce transcription of pro-inflammatory
g e n e ss u c ha si n d u c i b l ee n zymes, iNOS and COX-2 and
pro-inflammatory cytokines including TNF-a and IL-6
[32-34]. The activity of NF-B is suppressed in the cyto-
plasm in either the homodimer or a heterodimer form,
while it is complexed with an inhibitory IB protein. The
activation of NF-B results in the phosphorylation, ubi-
quitination, and proteasome-mediated degradation of the
IB proteins, followed by nuclear translocation [35,36].
The NF-B dimers are then free to translocate to the
nucleus and activate target genes. Recently, involvement
of the phosphoinositide 3-kinase (PI3K)/Akt pathway has
also been demonstrated in the expression of inflamma-
tory mediators in microglia through activation of NF-B
by IB degradation [37]. Therefore, blocking the NF-B
transcriptional activity and Akt activation has been iden-
tified as an important target for the treatment of inflam-
matory diseases. In the present study, we found that
spermidine treatment attenuated the phosphorylation
and degradation of IB in cytosol. The translocation of
NF-B factor p65, which is normally translocated from
the cytoplasm to the nucleus after exposure to LPS, was
also strongly inhibited by spermidine (Figure 5). The
increase in phosphorylation of Akt normally seen after
exposure to LPS was also markedly inhibited by spermi-
dine (Figure 6). These results suggest that the effects of
spermidine on the production of inflammatory mediators
and cytokines are at least partially mediated by the sup-
pression of the NF-B and PI3K/Akt signaling pathway.
In addition to NF-B, LPS is a potent activator of the
MAPKs pathway, which is the other major extracellular
signal transduction pathway stimulated by inflammatory
mediators. Once activated, MAPKs modulate the func-
tional responses of cells through phosphorylation of
transcription factors and activation of other kinases
[38,39]. The MAPKs are also known to be involved in
LPS-induced production of COX-2 and iNOS via
control of NF-B activation in microglial cells [40,41],
which indicates that MAPKs function as important tar-
gets for anti-inflammatory molecules. When investigated
the effects of spermidine on the LPS-induced phosphor-
ylation of MAPKs, we found that spermidine treatment
significantly inhibited LPS-stimulated phosphorylation of
p38 MAPK, ERK and JNK (Figure 6). This suggested
that the observed anti-inflammatory effects were also
due to inhibition of the MAPKs signaling pathway.
Conclusion
In conclusion, the present study has revealed that sper-
midine treatment of BV2 microglial cells inhibited LPS-
induced NO and PGE2 production by suppressing iNOS
and COX-2 mRNA and protein expression. Spermidine
also inhibited the production of pro-inflammatory cyto-
kines, such as TNF-a and IL-6, by suppressing their
transcriptional activity. These effects were exerted by
attenuation of translocation of NF-Bf r o mt h ec y t o -
plasm to the nucleus, which was accompanied by block-
ing of PI3K/Akt and MAPKs pathways. This suggests
that spermidine may have substantial therapeutic poten-
tial for treatment of neurodegenerative diseases that are
accompanied by microglial activation.
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